Effects of multiwall carbon nano-onions on platelet aggregation and hemostatic function.
- Author:
Gui-li YANG
1
;
Jie YANG
;
Jun ZHANG
;
Yu-ying XU
;
Qiao-hui WEI
;
Xiang-yu SUN
;
Xiao-min GU
;
Yin ZHANG
;
Qiu-ping DING
;
Yi-fan ZHENG
;
Jun YANG
;
Xin-qiang ZHU
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Bleeding Time; Blood Coagulation; drug effects; Carbon; administration & dosage; pharmacology; Hemostasis; drug effects; Male; Nanostructures; Partial Thromboplastin Time; Platelet Aggregation; drug effects; Platelet Count; Prothrombin Time; Rats; Rats, Sprague-Dawley; Thrombin Time
- From: Chinese Journal of Industrial Hygiene and Occupational Diseases 2011;29(5):321-323
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the effects of multiwall carbon nano-onions (MWCNOs) on platelet aggregation and hemostatic function.
METHODSThe platelet aggregation was determined with Born's method at different concentration of MWCNOs (0, 0.2, 2.0, 20.0 microg/ml) in vitro. Twenty male SD rats were randomly divided into 4 groups which were exposed to 0, 2, 4 and 8 mg/kg MWCNOs, respectively. Then platelet count, platelet aggregation, activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), bleeding time (BT) and platelet count (PC) were measured at 12 h after receiving tail intravenous injection of MWCNOs. The effects of MWCNOs (4 mg/kg) on platelet aggregation and platelet count at different time points were observed.
RESULTSIn vitro, MWCNOs exhibited the potent inhibitory effects on rat platelet aggregation caused by ADP in a concentration-dependent manner. The platelet aggregation in the highest dosage of 20.0 microg/ml group was 50.0% +/- 6.9% which was significantly lower than that (73.2% +/- 4.3%) in control group (P<0.01). In vivo, the highest inhibitory was up to 20.4%, but there was no significant difference, as compared with control group. MWCNOs did not affect the APTT, PT, TT, BT and PC.
CONCLUSIONUnder this experimental condition, MWCNOs might inhibit platelet aggregation but not affect hemostatic function.